Skip to content
10-Q

Quarterly Report

GILEAD SCIENCES, INC. GILD

0000882095-26-000024

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 1.24B sh
Shares Diluted Q1 2026 · Mar 31, 2026 1.25B sh
Shares Diluted Q1 2026 · Mar 31, 2025 1.26B sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $419M
Stock Repurchased Q1 2026 · Mar 31, 2025 $730M
Dividends Paid Q1 2026 · Mar 31, 2026 $1.04B
Dividends Paid Q1 2026 · Mar 31, 2025 $1.01B
Capex Q1 2026 · Mar 31, 2026 $117M
Capex Q1 2026 · Mar 31, 2025 $104M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $2.54B
Operating Cash Flow Q1 2026 · Mar 31, 2025 $1.76B
Long Term Debt Q1 2026 · Mar 31, 2026 $20.86B
Long Term Debt Q1 2026 · Dec 31, 2025 $22.13B
Short Term Debt Q1 2026 · Mar 31, 2026 $1.31B
Short Term Debt Q1 2026 · Dec 31, 2025 $2.81B
Stockholders Equity Q1 2026 · Mar 31, 2026 $23.52B
Stockholders Equity Q1 2026 · Dec 31, 2025 $22.7B
Current Liabilities Q1 2026 · Mar 31, 2026 $9.48B
Current Liabilities Q1 2026 · Dec 31, 2025 $11.81B
Current Assets Q1 2026 · Mar 31, 2026 $18.64B
Current Assets Q1 2026 · Dec 31, 2025 $18.34B
Total Assets Q1 2026 · Mar 31, 2026 $56.28B
Total Assets Q1 2026 · Dec 31, 2025 $59.02B
Eps Diluted Q1 2026 · Mar 31, 2026 $1.61
Eps Diluted Q1 2026 · Mar 31, 2025 $1.04
Eps Basic Q1 2026 · Mar 31, 2026 $1.63
Eps Basic Q1 2026 · Mar 31, 2025 $1.06
Sga Expense Q1 2026 · Mar 31, 2026 $1.45B
Sga Expense Q1 2026 · Mar 31, 2025 $1.26B
Net Income Q1 2026 · Mar 31, 2026 $2.02B
Net Income Q1 2026 · Mar 31, 2025 $1.32B
Operating Income Q1 2026 · Mar 31, 2026 $2.59B
Operating Income Q1 2026 · Mar 31, 2025 $2.24B
Cost Of Revenue Q1 2026 · Mar 31, 2026 $1.45B
Cost Of Revenue Q1 2026 · Mar 31, 2025 $1.54B
Revenue Q1 2026 · Mar 31, 2026 $6.96B
Revenue Q1 2026 · Mar 31, 2025 $6.67B